{"doi":"10.1016\/j.leukres.2008.07.025","coreId":"196934","oai":"oai:lra.le.ac.uk:2381\/9147","identifiers":["oai:lra.le.ac.uk:2381\/9147","10.1016\/j.leukres.2008.07.025"],"title":"Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells","authors":["Lugli, Enrico","Ferraresi, Roberta","Roat, Erika","Troiano, Leonarda","Pinti, Marcello","Nasi, Milena","Nemes, Elisa","Bertoncelli, Linda","Gibellini, Lara","Salomoni, Paolo","Cooper, Edwin L.","Cossarizza, Andrea"],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2009-01","abstract":"This paper was published as Leukemia Research, 2009, 33 (1), pp. 140-150.  It is available from http:\/\/www.sciencedirect.com\/science\/journal\/01452126.  Doi: 10.1016\/j.leukres.2008.07.025Metadata only entryToxicity of chemotherapeutic drugs towards normal cells is a serious side effect of cancer treatment. Thus, finding of molecules with low toxicity for normal cells is crucial. Several natural compounds, such as flavonoid quercertin, are receiving a growing attention as \u201cchemopreventers\u201d. Quercetin kills tumour-derived cell lines, but little is known about its effects on normal cells. Here we show that although quercetin exerts a higher apoptotic potential on leukemic cell lines than on peripheral blood mononuclear cells (PBMCs) and does not sensitize PBMCs to CD95-induced apoptosis, it is able to inhibit normal immune functions such as T cell proliferation and activation. Quercetin sensitivity is independent on cell cycle progression since it was not abrogated in serum-starved U937 cells, nor proliferating PBMCs underwent apoptosis after quercetin treatment. However, quercetin prevented PHA-induced PBMC proliferation and SEB-induced upregulation of activation markers. Our data suggest that quercetin, while incapable of inducing apoptosis in normal cells under several conditions, could interfere with effector T cell function","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"Elsevier","rawRecordXml":"<record><header><identifier>\n        \n            \n                oai:lra.le.ac.uk:2381\/9147<\/identifier><datestamp>\n                2011-03-08T16:54:35Z<\/datestamp><setSpec>\n                com_2381_37<\/setSpec><setSpec>\n                com_2381_9550<\/setSpec><setSpec>\n                col_2381_38<\/setSpec>\n            <\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:doc=\"http:\/\/www.lyncode.com\/xoai\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n            \nQuercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells<\/dc:title><dc:creator>\nLugli, Enrico<\/dc:creator><dc:creator>\nFerraresi, Roberta<\/dc:creator><dc:creator>\nRoat, Erika<\/dc:creator><dc:creator>\nTroiano, Leonarda<\/dc:creator><dc:creator>\nPinti, Marcello<\/dc:creator><dc:creator>\nNasi, Milena<\/dc:creator><dc:creator>\nNemes, Elisa<\/dc:creator><dc:creator>\nBertoncelli, Linda<\/dc:creator><dc:creator>\nGibellini, Lara<\/dc:creator><dc:creator>\nSalomoni, Paolo<\/dc:creator><dc:creator>\nCooper, Edwin L.<\/dc:creator><dc:creator>\nCossarizza, Andrea<\/dc:creator><dc:description>\nThis paper was published as Leukemia Research, 2009, 33 (1), pp. 140-150.  It is available from http:\/\/www.sciencedirect.com\/science\/journal\/01452126.  Doi: 10.1016\/j.leukres.2008.07.025<\/dc:description><dc:description>\nMetadata only entry<\/dc:description><dc:description>\nToxicity of chemotherapeutic drugs towards normal cells is a serious side effect of cancer treatment. Thus, finding of molecules with low toxicity for normal cells is crucial. Several natural compounds, such as flavonoid quercertin, are receiving a growing attention as \u201cchemopreventers\u201d. Quercetin kills tumour-derived cell lines, but little is known about its effects on normal cells. Here we show that although quercetin exerts a higher apoptotic potential on leukemic cell lines than on peripheral blood mononuclear cells (PBMCs) and does not sensitize PBMCs to CD95-induced apoptosis, it is able to inhibit normal immune functions such as T cell proliferation and activation. Quercetin sensitivity is independent on cell cycle progression since it was not abrogated in serum-starved U937 cells, nor proliferating PBMCs underwent apoptosis after quercetin treatment. However, quercetin prevented PHA-induced PBMC proliferation and SEB-induced upregulation of activation markers. Our data suggest that quercetin, while incapable of inducing apoptosis in normal cells under several conditions, could interfere with effector T cell function.<\/dc:description><dc:date>\n2011-03-08T16:52:49Z<\/dc:date><dc:date>\n2011-03-08T16:52:49Z<\/dc:date><dc:date>\n2009-01<\/dc:date><dc:type>\nArticle<\/dc:type><dc:identifier>\nLeukemia Research, 2009, 33 (1), pp. 140-150.<\/dc:identifier><dc:identifier>\n0145-2126<\/dc:identifier><dc:identifier>\nhttp:\/\/dx.doi.org\/10.1016\/j.leukres.2008.07.025<\/dc:identifier><dc:identifier>\nhttp:\/\/www.sciencedirect.com\/science\/journal\/01452126<\/dc:identifier><dc:identifier>\nhttp:\/\/hdl.handle.net\/2381\/9147<\/dc:identifier><dc:language>\nen<\/dc:language><dc:format>\nMetadata<\/dc:format><dc:publisher>\nElsevier<\/dc:publisher>\n<\/oai_dc:dc>\n<\/metadata>\n        <\/record>","journals":[{"title":null,"identifiers":["issn:0145-2126","0145-2126"]}],"language":null,"relations":[],"year":2009,"topics":[],"subject":["Article"],"fullText":null}